Prescription patterns and the cost of antihyperglycemic drugs in patients with diabetes mellitus in Iran from 2014 to 2019
Authors' conclusion
Insulin was the primary cost driver for antihyperglycemic medications. These cost disparities and variations in prescription patterns underscore the need for targeted interventions to improve diabetes care and manage resources effectively.
Study context
- Population
- Patients with diabetes mellitus (DM) in Iran, Iran Health Insurance prescriptions database, 2014–2019approx
- Outcome
- Prescription patterns and costs of antidiabetic medications
- Follow-up
- 2014–2019
Methodological detailshealth insurance prescriptions database
- Health insurance prescriptions database
Main finding
As reported in the abstract
2014–2019
Prescriptions analysed
20,233,608
Cost of females' vs males' antidiabetic medications (times higher)
1.66
Observational data: associations, not effects.
Original publication
Prescription patterns and the cost of antihyperglycemic drugs in patients with diabetes mellitus in Iran from 2014 to 2019. Diabetes Res Clin Pract. Published 15 March 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →